Haemonetics (HAE) Other Non Operating Income (2009 - 2026)
Haemonetics (HAE) posted quarterly Other Non Operating Income of -$5.4 million for Q1 2026, down 798.66% year-over-year from $769184.3 in Q1 2025, and up 27.58% quarter-over-quarter from -$7.4 million in Q4 2025.
Haemonetics (HAE) Other Non Operating Income (2009 - 2026) Analysis & Trends
Haemonetics' Other Non Operating Income history runs 18 years deep, the most recent figure standing at -$5.4 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 798.66% year-over-year to -$5.4 million; the TTM figure through Mar 2026 stood at -$28.7 million (down 194.52% YoY), while the FY2026 annual figure was -$28.7 million, down 194.52% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$5.4 million, up from -$7.4 million in the prior quarter.
- The five-year high for Other Non Operating Income was $7.0 million in Q2 2024, with the low at -$9.1 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$4.8 million (2022), against an average of -$4.1 million.
- The sharpest annual moves came in 2024 and 2026: Other Non Operating Income soared 436.25% in 2024, then tumbled 798.66% in 2026.
- Haemonetics' Other Non Operating Income stood at -$1.1 million in 2022, then plunged by 84.74% to -$1.9 million in 2023, then tumbled by 367.52% to -$9.1 million in 2024, then gained by 18.56% to -$7.4 million in 2025, then advanced by 27.58% to -$5.4 million in 2026.
- Business Quant data shows HAE's Other Non Operating Income at -$5.4 million in Q1 2026, -$7.4 million in Q4 2025, and -$7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn |
| 10 | Haemonetics | 4.77 Bn | 4.55 Bn | 202.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -9.88 Mn |
| Mar 28, 2026 | -5.37 Mn |
| Dec 27, 2025 | -7.42 Mn |
| Sep 27, 2025 | -7.21 Mn |
| Jun 28, 2025 | -8.70 Mn |
| Mar 29, 2025 | -598,000.00 |
| Dec 28, 2024 | -9.11 Mn |
| Sep 28, 2024 | -6.99 Mn |
| Jun 29, 2024 | 6.96 Mn |
| Mar 30, 2024 | -6.53 Mn |
| Dec 30, 2023 | -1.95 Mn |
| Sep 30, 2023 | -2.47 Mn |
| Jul 1, 2023 | -2.07 Mn |
| Apr 1, 2023 | -2.63 Mn |
| Dec 31, 2022 | -1.06 Mn |
| Oct 1, 2022 | -5.67 Mn |
| Jul 2, 2022 | -5.27 Mn |
| Apr 2, 2022 | -3.87 Mn |
| Jan 1, 2022 | -4.26 Mn |
| Oct 2, 2021 | -4.59 Mn |